Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dengzhan Shengmai capsule versus aspirin for carotid atherosclerosis
ChiCTR1900021365Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in carotid atheroma (CAS) comparing Dengzhan Shengmai capsule with Aspirin control (2 arms). Primary endpoint: Intima-media thickness. Started Mar 2019; status: completed.
02
Drugs
Dengzhan Shengmaiaspirin
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on ChiCTR1900021365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021365.